Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,717-1,728 of 4,306
Behavioral study icon
Not recruitingISRCTN85485447

Social Mind: improving social functioning in first episode psychosis

This study is looking at whether cognitive behavioural therapy can help people with First episode psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN75571732

Towards more effective European Community care for people with severe psychosis

This study is looking at whether questionnaires and follow-up can help people with Psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
European Commission
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN75347421

Traditional healers working with primary care and mental health for early intervention in psychosis in young persons

This study is looking at whether a mental health workshop can help people with First episode psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in a mental health workshop and complete follow-up assessments.

In Pakistan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 14 Years to 25 Years
Countries
Pakistan
Sponsor
Medical Research Council
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN85601537

Treating sleep problems in young people at ultra-high-risk of psychosis

This study is looking at whether questionnaires and follow-up can help people with Young people attending NHS mental health services with sleep problems who are at ultra-high-risk of psychosis, Mental and Behavioural Disorders, or Nonorganic sleep disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 14 Years to 25 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2005-005502-23

26-week open-label extension study evaluating the safety and tolerability of flexible doses of oral ziprasidone in adolescent subjects with schizophrenia.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Germany, Sweden
Sponsor
Pfizer AB
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2011-004790-90

A 12-WEEK, MULTICENTER, OPEN-LABEL EXTENSION STUDY IN SUBJECTS WITH SCHIZOPHRENIA

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Italy, Slovakia
Sponsor
Sunovion Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2012-003805-86

A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Latvia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Latvia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2016-001556-21

A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects with Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Hungary
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Hungary
Sponsor
SUNOVION PHARMACEUTICALS INC.
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2012-003806-28

A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients with Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Latvia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Latvia
Sponsor
Otsuka Pharmaceutical Development & Commercialization,
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2012-002785-12

A 28-week, randomised, open-label study evaluating the effectiveness of aripiprazole once-monthly versus paliperidone palmitate in adult patients with schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
United Kingdom, Czechia, Estonia, ...
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.